Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Advent International

Heidrick & Struggles Strengthens Board with Appointment of AI and Talent Leaders Aseem Datar and Leanne Wood

CHICAGO, June 22, 2026 /PRNewswire/ -- Heidrick & Struggles today announced the appointments of Aseem Datar, Corporate Vice President, AI Platform and Quantum at Microsoft, and Leanne Wood, former Chief Human Resources Officer at Vodafone, to the firm's Board of Managers, the company's governing body. The appointments follow the recent…

AAP

'Excited and terrified': One of private equity's top investors built an AI that knows every deal he's ever done

James Brocklebank of Advent International trained a robot on 13 years of investment committee papers. It sees things that a human can't—or won't.

Fortune

AI-Focused Waystar, Iodine Deal Wins Praise For Margin Upside

Waystar Holding (NASDAQ:WAY) on Wednesday agreed to acquire Iodine Software from shareholders led by Advent International, a private equity firm, for a total of $1.25 billion.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Reckitt strikes deal worth up to £3.6bn to sell Cillit Bang business

Advent International will buy a 70% stake in Reckitt’s essential home business, which also includes brands such as Air Wick.

The Independent UK

KKR clinches backing from Spectris for £4.1bn higher bid

Spectris had previously agreed a deal with US investment firm Advent International, which valued the firm at about £3.8 billion.

The Independent UK

Spectris agrees £3.8bn takeover by Advent as KKR mulls rival bid

Advent will pay £37.63 per share for the FTSE 250-listed company, valuing Spectris at £3.8 billion, or around £4.4 billion including debts.

Evening Standard

US group Advent International ‘preparing bid for Tate & Lyle’

Shares in food company jump 13% after reports Advent is in early stages of preparing an offer

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Yandex owner to exit Russia in .2B deal: Consortium

Yandex, the Russian search engine giant, is set to leave Russia in a .2 billion deal. Find out more about this significant move by the company.

Top News

Zimmermann becomes Australia’s first billion-dollar fashion label after private equity acquisition

Brand founders Simone and Nicky Zimmermann retain minority shareholding and say they and current management will continue to run the label

The Guardian - AU

Former HMV and DFS owner 'in talks to buy Subway in deal worth for up to $10billion'

Subway announced in February that its shareholders were "exploring" a sale of the sandwich global chain but did not share the details of the potential sale

Daily Mirror

UK marketing content firm Tag strikes £533m deal with Japan’s Dentsu

Exclusive: One of UK’s biggest ad deals for 15 years is expected to be signed this week but may yet fall through

The Guardian - UK

Suven Pharma promoters to sell 50.1% stake to PE player Advent for over Rs 6,300 crore

HYDERABAD: Suven Pharmaceuticals on Monday said its promoters, the Jasti family, are selling their 50.1% stake in the company to global private equity player Advent International for a consideration of over Rs 6,300 crore.

The Times of India

Yes Bank shares jump over 12% today: What led to rise in stock price

NEW DELHI: Shares of private lender Yes Bank has been performing well in the stock markets since the past few sessions. On Tuesday, the stock jumped nearly 13% and closed at Rs 17.14 on the BSE.

The Times of India

How Does Grupo Somar Acquisition Reaffirms Procaps' Strategy To Strengthen Footprint In LatAm

Integrated LatAm healthcare and pharmaceutical company Procaps Group (NASDAQ:PROC) has agreed to acquire Grupo Somar (including Grupo Farmacéutico Somar, Química y Farmacia, Gelcaps, and related entities) from Advent International, private equity. Deal terms were not disclosed. Grupo Somar is focused on developing, manufacturing, and marketing branded generic, private label, and OTC products targeted to…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.